Clin2
NCT06705023Possibly a fitRecruiting

Fat-derived cell therapy for heart failure

Myocardial InjuryLV DysfunctionCoronary Artery DiseaseHeart Failure

Part of Heart & circulation clinical trials.

This study tests whether taking a small amount of your own belly fat (through liposuction), processing it, and injecting the cells back into your heart can improve heart function in people with chronic heart failure due to blocked arteries. The trial is for patients whose heart pumps weakly (ejection fraction of 40% or less) and who are already on standard medications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
36 people
Ages
21 years to 80 years
Study type
Interventional

Who can take part

  • You have chronic heart failure from blocked arteries (ischemic) and your heart pumps less than 40% of blood out each beat.
  • You are on stable heart failure medicines for at least 1 month.
  • You are able to have a heart catheterization (a tube to check your heart's pressure).
  • You have not had a recent heart procedure (stent or bypass within 3 months), no severe valve problems, and no pacemaker or defibrillator made before 2015.
  • You do not have recent stroke (within 3 months), serious kidney disease, uncontrolled diabetes, active infections, or cancer (except treated skin cancer) in the last 3 years.
  • You are not pregnant or breastfeeding, and you agree to use birth control if able to become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06154044Recruiting· Phase 2
Cell therapy for heart recovery with LVAD support

This trial tests whether injecting special cells (cell therapy) can help the heart recover in people with advanced heart failure who are getting a mechanical heart pump (LVAD). It may offer a new way to improve heart function and quality of life.

Ljubljana
NCT07496372Recruiting· Phase 3
Stem cell injection for advanced heart failure

This trial tests a treatment made from stem cells that are turned into heart muscle cells and injected directly into the heart. It is for people with advanced heart failure who are already on the best available medicines and who are scheduled to have bypass surgery.

Tianjin, Tianjin Municipality
NCT06866600Not yet recruiting· Phase 1/Phase 2
Stem cell heart injections for severe heart failure

This trial tests whether injecting special heart muscle cells (made from stem cells) during a heart bypass or a heart pump surgery can help improve your heart's function. It is for people with severe heart failure who are already planning one of these surgeries.

Nanjing, Jiangsu
NCT07347197Not yet recruiting· Phase 1/Phase 2
Heart cell injection for heart failure with reduced pumping function

This trial tests whether injecting lab-grown heart cells into the heart can help people with heart failure whose heart pumps less than 40% of normal. It may help improve heart function and reduce symptoms.

NCT06956807Not yet recruiting· Phase 1
Heart patch with stem cells for damaged heart muscle

This trial tests whether placing a special membrane with stem cells on the heart during bypass surgery can help improve heart function in people with a weak heart after a previous heart attack.

Katowice - Ochojec
NCT05761067Recruiting
Trial for advanced heart weakness with low pumping ability

This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.

Gothenburg

Hear when a new Myocardial Injury trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.